References
- 1LouisED, MachadoDG Tremor-related quality of life: a comparison of essential tremor vs. Parkinson’s disease patients. Parkinsonism Relat Disord 2015;21:729–735. doi: 10.1016/j.parkreldis.2015.04.01925952960
- 2ZesiewiczTA, ElbleRJ, LouisED, Gronseth GS, Ondo WG, Dewey RB, et al. Evidence-based guideline update: treatment of essential tremor: report of the Quality Standards subcommittee of the American Academy of Neurology. Neurology 2011;77:1752–1755. doi: 10.1212/WNL.0b013e318236f0fd22013182
- 3ZappiaM, AlbaneseA, BrunoE, Colosimo C, Filippini G, Martinelli P, et al. Treatment of essential tremor: a systematic review of evidence and recommendations from the Italian Movement Disorders Association. J Neurol 2013;260:714–740. doi: 10.1007/s00415-012-6628-x22886006
- 4HorstinkM, TolosaE, BonuccelliU, Deuschl G, Friedman A, Kanovsky P, et al. Review of the therapeutic management of Parkinson’s disease. Report of a joint task force of the European Federation of Neurological Societies (EFNS) and the Movement Disorder Society-European Section (MDS-ES). Part II: late (complicated) Parkinson’s disease. Eur J Neurol 2006;13:1186–1202. doi: 10.1111/j.1468-1331.2006.01548.x17038032
- 5JankovicJ, SchwartzK, ClemenceW, AswadA, MordauntJ A randomized, double-blind, placebo-controlled study to evaluate botulinum toxin type A in essential hand tremor. Mov Disord 1996;11:250–256. doi: 10.1002/mds.8701103068723140
- 6HendersonJM, GhikaJA, Van MelleG, HallerE, EinsteinR Botulinum toxin A in non-dystonic tremors. Eur Neurol 1996;36:29–35. doi: 10.1159/0001171968719647
- 7BrinMF, LyonsKE, DoucetteJ, Adler CH, Caviness JN, Comella CL, et al. A randomized, double masked, controlled trial of botulinum toxin type A in essential hand tremor. Neurology 2001;56:1523–1528. doi:10.1212/wnl.56.11.152311402109
- 8PacchettiC, ManciniF, BulgheroniM, ZangagliaR, CristinaS, SandriniG, NappiG Botulinum toxin treatment for functional disability induced by essential tremor. Neurol Sci 2000;21:349–353. doi:10.1007/s10072007004911441571
- 9BainP, FindleyL, editors. Assessing tremor severity: a clinical handbook. London, United Kingdom: Smith-Gordon; 1993 ISBN 1-85463-099-7.
- 10KollerWC, BusenbarkK, HubbleJ Essential tremor. In: CalneDB, editor. Neurodegenerative diseases. Philedelphia, PA: WB Saunders; 1994, pp. 717–742. ISBN 0721643493.
- 11SamotusO, RahimiF, LeeJ, JogM Functional ability improved in essential tremor by IncobotulinumtoxinA injections using kinematically determined biomechanical patterns – A new future. PLoS One 2016;11(4):e0153739. doi: 10.1371/journal.pone.015373927101283
- 12SamotusO, LeeJ, JogM Long-term tremor therapy for Parkinson and essential tremor with sensor-guided botulinum toxin type A injections. PLoS One 2017;12(6):e0178670. doi: 10.1371/journal.pone.017867028586370
- 13SamotusO, KumarN, RizekP, JogM Botulinum toxin type A injections as monotherapy for upper limb essential tremor using kinematics. Can J Neurol Sci 2018;45:11–22. doi: 10.1017/cjn.2017.26029157315
- 14JogM, LeeJ, AlthausM, ScheschonkaA, DerschH, SimpsonD Efficacy and safety of incobotulinumtoxinA (Inco/A) for essential tremor of the upper limb using kinematics-guided clinical decision support: a randomized, double-blind, placebo-controlled trial. Mov Disord 2017;32(Suppl. 2):S451. doi:10.1002/mds.27087
- 15MittalSO, MachadoD, RichardsonD, DubeyD, JabbariB Botulinum toxin in essential hand tremor – A randomized double-blind placebo-controlled study with customized injection approach. Parkinsonism Relat Disord 2018;56:65–69. doi: 10.1016/j.parkreldis.2018.06.01929929813
- 16NiemannN, JankovicJ Botulinum toxin for the treatment of hand tremor. Toxins 2018;10:E299. doi: 10.3390/toxins1007029930029483
- 17RahimiF, BeeC, DebickiD, RobertsAC, BapatP, JogM Effectiveness of BoNT A in Parkinson’s disease upper limb tremor management. Can J Neurol Sci 2013;40:663–669. doi:10.1017/S031716710001489X23968939
- 18RahimiF, SamotusO, LeeJ, JogM Effective management of upper limb Parkinsonian tremor by IncobotulinumtoxinA injections using sensor-based biomechanical patterns. Tremor Hyperkinetic Mov 2015;5:348. doi: 10.7916/D8BP0270
- 19MittalSO, MachadoD, RichardsonD, DubeyD, JabbariB Botulinum toxin in Parkinson disease tremor: a randomized, double-blind, placebo-controlled study with a customized injection approach. Mayo Clin Proc 2017;92:1359–1367. doi: 10.1016/j.mayocp.2017.06.01028789780
- 20VielotteJ Effectiveness of intramuscular injections of botulinum toxin in the treatment of disabling cerebellar tremor of the hand. Ann Phys Rehabil Med 2016;59(S):e142. doi: 10.1016/j.rehab.2016.07.319
- 21KimSD, YiannikasC, MahantN, VucicS, FungVSC Treatment of proximal upper limb tremor with botulinum toxin therapy. Mov Disord 2014;29:835–838. doi: 10.1002/mds.2573924519658
- 22BhatiaKP, BainP, BajajN, Elble RJ, Hallett M, Louis ED, et al. Consensus statement on the classification of tremors, from the task force on tremor of the International Parkinson and Movement Disorder Society. Mov Disord 2018;33:75–87. doi: 10.1002/mds.2712129193359
- 23TrösterAI, PahwaR, FieldsJA, TannerCM, LyonsKE Quality of life in Essential Tremor Questionnaire (QUEST): development and initial validation. Parkinsonism Relat Disord 2005;11:367–373. doi: 10.1016/j.parkreldis.2005.05.00916103000
- 24TraubRE, GerbinM, MullaneyMM, LouisED Development of an essential tremor embarrassment assessment. Parkinsonism Relat Disord 2010;16:661–665. doi: 10.1016/j.parkreldis.2010.08.01720869901
- 25GuyW Clinical global impressions. In: ECDEU assessment manual for psychopharmacology, revised. Rockville, MD: National Institute of Mental Health; 1973, pp. 217–221.
- 26KollerWC, Vetere-OverfieldB Acute and chronic effects of propranolol and primidone in essential tremor. Neurology 1989;39:1587–1588. doi.org/10.1212/WNL.39.12.15872586774
- 27RajputAH, RajputA Medical treatment of essential tremor. J Cent Nerv Syst Dis 2014;6:29–39. doi: 10.4137/JCNSD.S1357024812533
- 28PicilloM, FasanoA Recent advances in essential tremor: surgical treatment. Parkinsonism Relat Disord 2016;22 Suppl 1:S171–S175. doi: 10.1016/j.parkreldis.2015.09.01226382842
- 29WitjasT, CarronR, KrackP, Eusebio A, Vaugoyeau M, Hariz M, et al. A prospective single-blind study of Gamma Knife thalamotomy for tremor. Neurology 2015;85:1562–1568. doi: 10.1212/WNL.000000000000208726446066
- 30LouisED, FerreiraJJ How common is the most common adult movement disorder? Update on the worldwide prevalence of essential tremor. Mov Disord 2010;25:534–541. doi: 10.1002/mds.2283820175185
- 31BuhmannC, HuckhagelT, EngelK, Gulberti A, Hidding U, Poetter-Nerger M, et al. Adverse events in deep brain stimulation: a retrospective long-term analysis of neurological, psychiatric and other occurrences. PLoS One 2017;12(7):e0178984. doi: 10.1371/journal.pone.017898428678830
- 32TaskerRR Deep brain stimulation is preferable to thalamotomy for tremor suppression. Surg Neurol 1998;49:145–153. doi:10.1016/S0090-3019(97)00459-X9457264
- 33RainaGB, CersosimoMG, FolgarSS, Giugni JC, Calandra C, Paviolo JP, et al. Holmes tremor: clinical description, lesion localization, and treatment in a series of 29 cases. Neurology 2016;86:931–938. doi: 10.1212/WNL.000000000000244026865524
- 34KobayashiK, KatayamaY, OshimaH, Watanabe M, Sumi K, Obuchi T, et al. Multitarget, dual-electrode deep brain stimulation of the thalamus and subthalamic area for treatment of Holmes’ tremor. J Neurosurg 201;120:1025–1032. doi: 10.3171/2014.1.JNS1239224605838
- 35Ramirez-ZamoraA, OkunMS Deep brain stimulation for the treatment of uncommon tremor syndromes. Expert Rev Neurother 2016;16:983–997. doi: 10.1080/14737175.2016.119475627228280
- 36PlahaP, KhanS, GillSS Bilateral stimulation of the caudal zona incerta nucleus for tremor control. J Neurol Neurosurg Psychiatry 2008;79:504–513. doi: 10.1136/jnnp.2006.11233418037630
- 37HaiC, Yu-pingW, HuaW, YingS Advances in primary writing tremor. Parkinsonism Relat Disord 2010;16:561–565. doi: 10.1016/j.parkreldis.2010.06.01320630791
- 38PandeyS, SarmaN Tremor in dystonia. Parkinsonism Relat Disord 2016;29:3–9. doi: 10.1016/j.parkreldis.2016.03.02427062584